Still too soon to say if Omicron more transmissible than Delta: WHO

The UN agency's experts regularly meet drugmakers to discuss the best composition of COVID-19 vaccines as the industry looks at whether shots need to be tweaked to tackle the coronavirus.

World Health Organisation, WHO
Reuters
2 min read Last Updated : Dec 22 2021 | 9:50 PM IST
The World Health Organization does not yet have enough data on the new Omicron variant of the coronavirus to say if it is more transmissible than the Delta variant, an official said on Wednesday, almost a month after South Africa first raised the alarm about its emergence.

"We do have some data suggesting that rates of hospitalisation are lower," WHO's technical lead on COVID-19, Maria van Kerkhove, said in a briefing with media.

But she cautioned against drawing conclusions from the early data because "we have not seen this variant circulate long enough in populations around the world, certainly in vulnerable populations".

She said the data on the new variant, first identified in southern Africa and Hong Kong in November, was still "messy" as countries reported its arrival and spread.

The U.N. agency's experts regularly meet drugmakers to discuss the best composition of COVID-19 vaccines as the industry looks at whether shots need to be tweaked to tackle the coronavirus.

The comments on Omicron came as a South African study suggested that those infected with Omicron were significantly less likely to end up in hospital than those with Delta, although the authors said some of that was probably due to high levels of immunity in the population.

The head of the WHO, Tedros Adhanom Ghebreyesus, urged countries to learn from the past two years of the pandemic, calling again for greater vaccine equity, in the hope of next year ending a pandemic that has killed over 5.6 million people around the world.

"As we approach the new year, we must all learn the painful lessons this year has taught us. 2022 must be the end of the COVID-19 pandemic," he said.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusWHOWorld Health Organisation

Next Story